SCHEMBL368555

SCHEMBL368555

Cc1cc(Cl)ccc1C(CC(=O)c1ccc(=O)n(C)c1)c1ccc(C(=O)NCCO)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCG P01275 2/20 0.37
POLB P06746 4/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 1/20 0.36
HTT P42858 1/20 0.36
GCGR P47871 3/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
CREBBP Q92793 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MMP13 P45452 1/20 0.34
LMNA P02545 1/20 0.34
EPHX2 P34913 2/20 0.34
BRD4 O60885 2/20 0.34
GIPR P48546 1/20 0.34
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368098 0.90 GCG (0.39) GCGPOLBHPGDHSD17B10HTT
SCHEMBL369879 0.90 GPBAR1 (0.37) GCGPOLBHPGDHSD17B10HTT
SCHEMBL369877 0.90 GPBAR1 (0.37) GCGPOLBHPGDHSD17B10HTT
SCHEMBL369878 0.90 GPBAR1 (0.37) GCGPOLBHPGDHSD17B10HTT
SCHEMBL368212 0.90 TP53 (0.36) GCGPOLBGCGRCREBBPALDH1A1
SCHEMBL1390515 0.89 MAPK14 (0.35) GCGPOLBHPGDCREBBPALDH1A1
SCHEMBL369230 0.89 MAPK14 (0.35) GCGPOLBHPGDCREBBPALDH1A1
SCHEMBL1390430 0.87 EPHX2 (0.40) POLBHTTCREBBPALDH1A1MMP13
SCHEMBL369581 0.86 POLB (0.40) POLBCREBBPMEN1KMT2AL3MBTL1
SCHEMBL370765 0.86 CYP2C9 (0.39) POLBCREBBPBRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
CN-103153945-A 1-oximino-3-phenyl-propanes HOFFMANN LA ROCHE 2013-06-12 CN disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GCG 347/4885POLB 2940/4885HPGD 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.